Adage Capital Partners
MNTA

Adage Capital Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Adage Capital Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,221,738
Closed -$117M – 914
2020
Q3 		$117M Buy
2,221,738
+171,738
+8% +$7.11M 0.29% 75
2020
Q2 		$68.2M Sell
2,050,000
-70,000
-3% -$2.23M 0.17% 139
2020
Q1 		$57.7M Buy
+2,120,000
New +$59M 0.17% 150

Adage Capital Partners's MNTA Position: Q4 2020 in Review

Adage Capital Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 2,221,738 shares — an estimated $117M sold.

Adage Capital Partners first reported a position in MNTA in Q1 2020 and held it in 3 quarters. The position peaked at $117M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Adage Capital Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Adage Capital Partners sold 2,221,738 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $117M.
  • Adage Capital Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
  • Adage Capital Partners's Momenta Pharmaceuticals, Inc. position peaked at $117M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.